# Antiplatelet Therapy and Cardiovascular Diseases

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 921,645 |
| Description | This cluster of papers focuses on the use of antiplatelet therapy, including aspirin, clopidogrel, and ticagrelor, in the prevention of cardiovascular events, especially in the context of percutaneous coronary intervention. It also explores the impact of genetic polymorphisms, platelet reactivity, and bleeding risk on the efficacy and safety of antiplatelet drugs. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | https://openalex.org/T11064 |
| Works | 62,682 |

## Topic researchers

Showing 12 of 20.

- [David Moher](https://scholariq.org/researchers/david-moher/)
- [Eric S. Lander](https://scholariq.org/researchers/eric-s-lander/)
- [Walter C. Willett](https://scholariq.org/researchers/walter-c-willett/)
- [Stacey Gabriel](https://scholariq.org/researchers/stacey-gabriel/)
- [Julian P. T. Higgins](https://scholariq.org/researchers/julian-p-t-higgins/)
- [John J.V. McMurray](https://scholariq.org/researchers/john-j-v-mcmurray/)
- [Cyrus Cooper](https://scholariq.org/researchers/cyrus-cooper/)
- [Emelia J. Benjamin](https://scholariq.org/researchers/emelia-j-benjamin/)
- [Stephan Windecker](https://scholariq.org/researchers/stephan-windecker/)
- [Giuseppe Remuzzi](https://scholariq.org/researchers/giuseppe-remuzzi/)
- [Matthias Egger](https://scholariq.org/researchers/matthias-egger/)
- [Gordon Guyatt](https://scholariq.org/researchers/gordon-guyatt/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.